| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |